ArticleJournal of the American Heart Association2015
Disparity in Mortality From Rheumatic Heart Disease in Indigenous Australians.
Article in Journal of the American Heart Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 31 citations in OpenAlex.
- Clinical characteristics and predictors of adverse outcomes in children with acute rheumatic fever from a high-endemic region of Brazil.Frontiers in cardiovascular medicine · 2026Article
- Sudden cardiac death in young First Nations Australians in the Northern Territory, Australia: Potential implications for pre-participation screening.JSAMS plus · 2025Article
- Connections Reduce Rheumatic Heart Disease-Related Mortality in Western Australia: A Mixed Methods Study.The Australian journal of rural health · 2025Article
- Rheumatic heart disease burden from 1990 to 2021: an updated analysis based on the global burden of disease study 2021.Frontiers in public health · 2025Article
- Changes in the burden and underlying causes of rheumatic heart disease in children and youths, 1990-2021: an analysis of the Global Burden of Disease Study 2021.Frontiers in cardiovascular medicine · 2025Article
- Excess Deaths Associated with Rheumatic Heart Disease, Australia, 2013-2017.Emerging infectious diseases · 2024Article
- Temporal Trends of Age-Adjusted Mortality Rates for Rheumatic Heart Disease in Brazil From 2000 to 2021.Cureus · 2024Article
- Chest pain epidemiology and care quality for Aboriginal and Torres Strait Islander peoples in Victoria, Australia: a population-based cohort study from 2015 to 2019.The Lancet regional health. Western Pacific · 2023Article
- Surgery for rheumatic heart disease in the Northern Territory, Australia, 1997-2016: what have we gained?BMJ global health · 2023Article
- Survival of Rheumatic Heart Disease in Indonesian Children.Global heart · 2022Article
- Long-term outcomes following rheumatic heart disease diagnosis in Australia.European heart journal open · 2021Article
- Contemporary Incidence and Prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia Using Linked Data: The Case for Policy Change.Journal of the American Heart Association · 2020Article
- The End Rheumatic Heart Disease in Australia Study of Epidemiology (ERASE) Project: data sources, case ascertainment and cohort profile.Clinical epidemiology · 2019Article
- Prevalence of rheumatic heart disease in Zambian school children.BMC cardiovascular disorders · 2018Observational
- Article
- Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort.European journal of preventive cardiology · 2017Article
- Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.Circulation · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent estimates of the global burden of rheumatic heart disease (RHD) have highlighted the paucity of reliable RHD mortality data from populations most affected by RHD. METHODS AND
resultsWe investigated RHD mortality rates and trends for Indigenous and non-Indigenous Australians in the Northern Territory (NT) for the period 1977-2005 and seminationally (NT plus 4 other states, covering 89% of Indigenous Australians) from 1997 to 2005 using vital statistics data. All analysis was undertaken by Indigenous status, sex, and age at death. In the NT, 90% of all deaths from RHD were among Indigenous persons; however, the Indigenous population makes up only 30.4% of the NT population. The death rate ratio (Indigenous compared with non-Indigenous) was 54.80 in the NT and 12.74 in the other 4 states (estimated at the median age of 50 years). Non-Indigenous death rates were low for all age groups except ≥65 years, indicating RHD deaths in the elderly non-Indigenous population. Death rates decreased at a more rapid rate for non-Indigenous than Indigenous persons in the NT between 1997 and 2005. Indigenous persons in other parts of Australia showed lower death rates than their NT counterparts, but the death rates for Indigenous persons in all states were still much higher than rates for non-Indigenous Australians.
conclusionsIndigenous Australians are much more likely to die from RHD than other Australians. Among the Indigenous population, RHD mortality is much higher in the NT than elsewhere in Australia, exceeding levels reported in many industrialized countries more than a century ago. With the paucity of data from high-prevalence areas, these data contribute substantially to understanding the global burden of RHD mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.